2019
DOI: 10.1182/hematology.2019000034
|View full text |Cite
|
Sign up to set email alerts
|

Management of iron deficiency

Abstract: Iron deficiency (ID) affects billions of people worldwide and remains the leading cause of anemia with significant negative impacts on health. Our approach to ID and iron deficiency anemia (IDA) involves three steps (I3): (1) identification of ID/IDA, (2) investigation of and management of the underlying etiology of ID, and (3) iron repletion. Iron repletion options include oral and intravenous (IV) iron formulations. Oral iron remains a therapeutic option for the treatment of ID in stable patients, but there … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
94
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(98 citation statements)
references
References 65 publications
1
94
0
3
Order By: Relevance
“…Iron is administrated at a dose of 4-6 mg/kg/day divided into three-times-a-day dose or single-daily dose on an empty stomach (2,9,15). Reticulocytosis starts on day 3 and reaches a peak in 5-7 days (16). Due to the rarity of pancytopenia in the context of iron deficiency, there is no clear evidence in the literature to determine the time to recovery of leukopenia and thrombocytopenia (4-6).…”
Section: Discussionmentioning
confidence: 99%
“…Iron is administrated at a dose of 4-6 mg/kg/day divided into three-times-a-day dose or single-daily dose on an empty stomach (2,9,15). Reticulocytosis starts on day 3 and reaches a peak in 5-7 days (16). Due to the rarity of pancytopenia in the context of iron deficiency, there is no clear evidence in the literature to determine the time to recovery of leukopenia and thrombocytopenia (4-6).…”
Section: Discussionmentioning
confidence: 99%
“…Currently, three IV iron formulations (iron sucrose, ferric carboxymaltose, and iron isomaltoside) are most commonly used because they do not have serious side effects [26]. Many studies have compared the e cacy and safety of different IV iron formulations [27][28][29][30]. Derman et al [28] analyzed IV iron isomaltoside and IV iron sucrose administration and found that iron isomaltoside required fewer administrations and showed a higher and faster Hb response than iron sucrose administration.…”
Section: Discussionmentioning
confidence: 99%
“…hemoglobin and myoglobin [10]. Fe deficiency is the predominant cause of anemia, affecting 27% of global population [11]. Fe deficiency and anemia lead to impaired cognitive development, immune suppression, fatigue, low-birth weight of infants, increased mortality and morbidity [12,13].…”
Section: Introductionmentioning
confidence: 99%